- Home
- ASIX vs GOSS Comparison
ASIX vs GOSS Comparison
Compare ASIX & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASIX
- GOSS
- Stock Information
- Founded
- ASIX 2016
- GOSS 2015
- Country
- ASIX United States
- GOSS United States
- Employees
- ASIX N/A
- GOSS N/A
- Industry
- ASIX Major Chemicals
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- ASIX Industrials
- GOSS Health Care
- Exchange
- ASIX Nasdaq
- GOSS Nasdaq
- Market Cap
- ASIX 561.0M
- GOSS 586.6M
- IPO Year
- ASIX N/A
- GOSS 2019
- Fundamental
- Price
- ASIX $21.11
- GOSS $3.18
- Analyst Decision
- ASIX Buy
- GOSS Strong Buy
- Analyst Count
- ASIX 1
- GOSS 6
- Target Price
- ASIX $32.00
- GOSS $8.60
- AVG Volume (30 Days)
- ASIX 197.9K
- GOSS 4.4M
- Earning Date
- ASIX 10-31-2025
- GOSS 11-06-2025
- Dividend Yield
- ASIX 3.03%
- GOSS N/A
- EPS Growth
- ASIX 829.30
- GOSS N/A
- EPS
- ASIX 2.84
- GOSS N/A
- Revenue
- ASIX $1,515,062,000.00
- GOSS $40,237,000.00
- Revenue This Year
- ASIX $7.41
- GOSS N/A
- Revenue Next Year
- ASIX $4.60
- GOSS $30.65
- P/E Ratio
- ASIX $7.43
- GOSS N/A
- Revenue Growth
- ASIX 1.31
- GOSS N/A
- 52 Week Low
- ASIX $17.97
- GOSS $0.66
- 52 Week High
- ASIX $33.00
- GOSS $3.60
- Technical
- Relative Strength Index (RSI)
- ASIX 52.38
- GOSS 66.52
- Support Level
- ASIX $20.50
- GOSS $2.61
- Resistance Level
- ASIX $21.85
- GOSS $3.60
- Average True Range (ATR)
- ASIX 0.61
- GOSS 0.28
- MACD
- ASIX 0.10
- GOSS 0.07
- Stochastic Oscillator
- ASIX 49.97
- GOSS 65.71
About ASIX AdvanSix Inc.
AdvanSix Inc. is a diversified chemistry company playing a critical role in globally supply chains, innovating and delivering essential products for customers in a wide variety of end markets and applications that touch people's lives, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics. The company key products includes: Nylon, Caprolactam, Plant Nutrients, and Chemical Intermediates The majority of sales is from Plant Nutrients products.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.